|
|
||||||||||||||
|
Journal Articles
27. Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening S.N. Dighe^, G.S. Deora^, E. De la Mora, F. Nachon, S. Chan, M.-O. Parat, X. Brazzolotto, B.P. Ross Journal of Medicinal Chemistry 2016, doi:10.1021/acs.jmedchem.6b00356 ^ These authors contributed equally to this work
26. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease S. Chan^, S. Kantham^, V.M. Rao, M.K. Palanivelu, H.L. Pham, P.N. Shaw, R.P. McGeary, B.P. Ross Food Chemistry 2016, 199, 185-194 doi:10.1016/j.foodchem.2015.11.118 ^ These authors contributed equally to this work
25. "Click" Assembly of Glycoclusters and Discovery of a Trehalose Analogue that Retards Aβ40 Aggregation and Inhibits Aβ40-induced Neurotoxicity H. Rajaram, M.K. Palanivelu, T.V. Arumugam, V.M. Rao, P.N. Shaw, R.P. McGeary, B.P. Ross Bioorganic & Medicinal Chemistry Letters 2014, 24, 4523-4528 doi:10.1016/j.bmcl.2014.07.077
24. Cyclodextrin-crosslinked poly(acrylic acid): Adhesion and controlled release of diflunisal and fluconazole from solid dosage forms M.J. Kutyla, M.W. Boehm, J.R. Stokes, P.N. Shaw, N.M. Davies, R.P. McGeary, J. Tuke, B.P. Ross AAPS PharmSciTech 2013, 14, 301-311
23. Cyclodextrin-crosslinked poly(acrylic acid): Synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels M.J. Kutyla, L.K. Lambert, N.M. Davies, R.P. McGeary, P.N. Shaw, B.P. Ross International Journal of Pharmaceutics 2013, 444, 175-184 doi:10.1016/j.ijpharm.2013.01.005
22. Enzyme-Responsive Controlled Release of Covalently Bound Prodrug from Functional Mesoporous Silica Nanospheres A. Popat, B.P. Ross, J.Liu, S. Jambhrunkar, F. Kleitz, S.Z. Qiao Angewandte Chemie International Edition 2012, 51, 12486-12489
21. 2-Mercaptobenzothiazole and its Derivatives: Syntheses, Reactions and Applications F.-L. Wu, W.M. Hussein, B.P. Ross, R.P. McGeary Current Organic Chemistry 2012, 16, 1555-1580 doi:10.2174/138527212800840964
20. Phytochemical Study of Fagraea spp. Uncovers A New Terpene Alkaloid with Anti-Inflammatory Properties S. Suciati, L.K. Lambert, B.P. Ross, M.A. Deseo, M.J. Garson Australian Journal of Chemistry 2011, 64, 489-494
19. New Methodology for the Conversion of Epoxides to Alkenes F.-L. Wu, B.P. Ross, R.P. McGeary European Journal of Organic Chemistry 2010, 10, 1989-1998
18. Synthetic Approaches to Functionalized Lipids for Protein Monolayer Crystallizations W.M. Hussein, B.P. Ross, M.J. Landsberg, B. Hankamer, R.P. McGeary Current Organic Chemistry 2009, 13, 1378-1405 doi:10.2174/138527209789055081
S. Ramli, I.R. Gentle, B.P. Ross Protein & Peptide Letters 2009, 16, 810-814 doi:10.2174/092986609788681706 Link to the post-print manuscript
16. Synthesis of cationic derivatives of Quil A and the preparation of cationic immune-stimulating complexes (ISCOMs) H.L. Pham, B.P. Ross, R.P. McGeary, P.N. Shaw, N.M. Davies International Journal of Pharmaceutics 2009 , 376, 123-133 doi:10.1016/j.ijpharm.2009.04.011
15. An "inside-out" approach to suramin analogues R.P. McGeary, A.J. Bennett, Q.B. Tran, J. Prins, B.P. Ross Tetrahedron 2009, 65, 3990-3997
14. Synthesis of Nickel-Chelating Fluorinated Lipids for Protein Monolayer Crystallizations W.M. Hussein, B.P. Ross, D. Lévy, M.J. Landsberg, B. Hankamer, R.P. McGeary Journal of Organic Chemistry 2009, 74, 1473-1479
13. Suramin: Clinical Uses and Structure-Activity Relationships R.P. McGeary, A.J. Bennett, Q.B. Tran, K.L. Cosgrove, B.P. Ross Mini-Reviews in Medicinal Chemistry 2008, 8, 1384-1394 doi:10.2174/138955708786369573
12. N-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (N-Dde) Lipoamino Acids B.P. Ross, R.A. Falconer, I. Toth Molbank 2008, M566
11. Caco-2 Cell Permeability and Stability of Two D-Glucopyranuronamide Conjugates of Thyrotropin-Releasing Hormone S.T. Wessling, B.P. Ross, Y. Koda, J.T. Blanchfield, I. Toth Bioorganic & Medicinal Chemistry 2007, 15, 4946-4950
10. Rhodamine B Pentyl Ester and its Methyl, Ethyl, Propyl, and Butyl Homologues J.A. Ross, B.P. Ross, K.L. Cosgrove, H. Rubinsztein-Dunlop, R.P. McGeary Molbank 2006, M515
9. Saponins from Quillaja saponaria Molina: Isolation, Characterization and Ability to Form Immuno Stimulatory Complexes (ISCOMs) H.L. Pham, B.P. Ross, R.P. McGeary, P.N. Shaw, A.K. Hewavitharana, N.M. Davies Current Drug Delivery 2006, 3, 389-397 doi:10.2174/156720106778559092
8. Determination of the Anomeric Configurations of 2,3,4,6-Tetra-O-Acetyl-D-Mannopyranosyl Azide K.L. Cosgrove, P.V. Bernhardt, B.P. Ross, R.P. McGeary Australian Journal of Chemistry 2006, 59, 473-476
7. Facile Synthesis of Rhodamine Esters Using Acetyl Chloride in Alcohol Solution J.A. Ross, B.P. Ross, H. Rubinsztein-Dunlop, R.P. McGeary Synthetic Communications 2006, 36, 1745-1750
6. Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin P.Y. Hayes, B.P. Ross, B.G. Thomas, I. Toth Bioorganic & Medicinal Chemistry 2006, 14, 143-152
5. Gastrointestinal Absorption of Heparin by Lipidization or Coadministration with Penetration Enhancers B.P. Ross, I. Toth Current Drug Delivery 2005, 2, 277-287
4. Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin B.P. Ross, S.E. DeCruz, T.B. Lynch, K. Davis-Goff, I. Toth Journal of Medicinal Chemistry 2004, 47, 1251-1258
3. Micellar Aggregation and Membrane Partitioning of Bile Salts, Fatty Acids, Sodium Dodecyl Sulfate, and Sugar-Conjugated Fatty Acids: Correlation with Hemolytic Potency and Implications for Drug Delivery B.P. Ross, A.C. Braddy, R.P. McGeary, J.T. Blanchfield, L. Prokai, I. Toth Molecular Pharmaceutics 2004, 1, 233-245
2. Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues A.K. Wong, B.P. Ross, Y.-N. Chan, P. Artursson, L. Lazorova, A. Jones, I. Toth European Journal of Pharmaceutical Sciences 2002, 16, 113-118 doi:10.1016/S0928-0987(02)00078-7
1. Halogenated Terpenoids. XXXII. Pentabromides from Limonene -Two 1,2,8,9,9-Pentabromo-p-menthanes P.V. Bernhardt, R.M. Carman, B.P. Ross Australian Journal of Chemistry 2000, 53, 611-614
Patents
Oral drug delivery systems comprising ionic complexes including mono- or oligosaccharide, lipidic moiety, and optionally a linker and/or a spacer. Toth I, Falconer R, De Cruz S E, McGeary R P, Ross B P (2007) US7312194-B2; US20040176281-A1; WO2002053572-A1 [Continuation-in-part of Appl. No. PCT/AU02/5].
New amide-linked mono, di and tri-saccharide-lipoamino acid complex useful in drug delivery Toth I, Falconer R, De Cruz S E, McGeary R P, Ross B P (2002) WO200253572-A; WO200253572-A1; AU2002216843-A1; US2004176281-A1
|
Latest News
2 April 2013: Welcome Mr Suresh Veliyath (PhD candidate). Suresh has a masters degree in pharmaceutical chemistry from Rajiv Gandhi University, Bangalore. He worked as a project assistant at the Indian Institute of Science (IISC) Bangalore and as a faculty member at MIPS Hyderabad, before joining the Ross Group. Suresh's PhD project is focused on AD drug discovery.
6 February 2013: Welcome Mr Girdhar Singh Deora (PhD candidate). Giri completed a MPharm from Rajiv Gandhi Technological University, Bhopal in 2009. Prior to joining the Ross Group, Giri worked as a research associate at Rajiv Gandhi Technological University (2010-11) and at Dr Reddy's Institute of Life Sciences, Hyderabad (2011-13). Giri's PhD project is in the field of AD drug discovery.
10 January 2013: Welcome Mr Edward Lee (PhD candidate). Eddy completed a BPharm (2010) and postgraduate honours (2012) degrees at UQ and he was awarded an APA scholarship for his PhD project to develop anti-viral nanoparticles.
1 November 2012: Welcome Mr Satish Dighe (PhD candidate). Satish was awarded an MPharm in 2009 from Pune University, and worked as a research chemist at Zydus-Cadila Healthcare Limited (2009-11; Ahmedabad) and as a research assistant at the Birla Institute of Techology and Science (2011-12; Pilani), before joining the Ross Group. The topic of Satish's PhD project is AD drug discovery.
3 July 2012: Welcome Mr Srinivas Kantham (PhD candidate) who is funded by a prestigious Prime Minister's Australia Asia Incoming Postgraduate Award. For his PhD Srinivas is developing polyphenols as disease-modifying drugs for AD. Previously he worked as a research assistant at the Indian Institute of Chemical Technology (IICT) Hyderabad.
|
Contact
Dr Ben Ross
Courier address: School of Pharmacy, The University of Queensland, 20 Cornwall Street, Woolloongabba, Qld 4102, Australia
Postal address: School of Pharmacy, The University of Queensland, Brisbane, Qld 4072, Australia
Phone: +61 7 334 61900 Fax: +61 7 334 61999
Email:
|
 |
This web site was last updated on 16 December 2015. Copyright © 2006-2016 Benjamin P. Ross. Unless stated otherwise, this web site represents only the views of Benjamin P. Ross and not the views of The University of Queensland. Simple site map. |
